APA (7th ed.) Citation

Ueshima, S., Hira, D., Fujii, R., Kimura, Y., Tomitsuka, C., Yamane, T., . . . Katsura, T. (2017). Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation. Pharmacogenetics and genomics, 27(9), 329. https://doi.org/10.1097/FPC.0000000000000294

Chicago Style (17th ed.) Citation

Ueshima, Satoshi, et al. "Impact of ABCB1, ABCG2, and CYP3A5 Polymorphisms on Plasma Trough Concentrations of Apixaban in Japanese Patients with Atrial Fibrillation." Pharmacogenetics and Genomics 27, no. 9 (2017): 329. https://doi.org/10.1097/FPC.0000000000000294.

MLA (9th ed.) Citation

Ueshima, Satoshi, et al. "Impact of ABCB1, ABCG2, and CYP3A5 Polymorphisms on Plasma Trough Concentrations of Apixaban in Japanese Patients with Atrial Fibrillation." Pharmacogenetics and Genomics, vol. 27, no. 9, 2017, p. 329, https://doi.org/10.1097/FPC.0000000000000294.